Liver involvement in acute vaso-occlusive crisis of sickle cell disease: Prevalence and predisposing factors

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 4, 2007, Pages 499-507

  Koskinas, John ^a   Manesis, Emanuel K ^a   Zacharakis, George H ^a   Galiatsatos, Nikolaos ^a   Sevastos, Nikolaos ^a   Archimandritis, Athanasios J ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Liver involvement; Sickle cell crisis; Spleen function

Indexed keywords

BILIRUBIN; ENZYME; ISOENZYME;

ADOLESCENT; ADULT; APACHE; ARTICLE; ASPLENIA; BETA THALASSEMIA; BILIRUBIN BLOOD LEVEL; CHEMICAL PARAMETERS; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEPATOMEGALY; HOSPITALIZATION; HUMAN; LIVER CELL DAMAGE; LIVER VENOOCCLUSIVE DISEASE; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SICKLE CELL ANEMIA; SPLEEN FUNCTION; THROMBOCYTE COUNT;

ACUTE DISEASE; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; FEMALE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED;

EID: 34147166638     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600988212     Document Type: Article

References (46)

1. Christakis J, Vavatsi N, Hassapopoulou H, Angeloudi M, Papadopoulou M, Loukopoulos D, et al. A comparison of sickle cell syndromes in Northern Greece. Br J Haematol 1991;77:386-91 .
2. Loukopoulos D. Current status of thalassemia and the sickle cell syndromes in Greece. Semin Hematol 1996;33:76-86.
3. Nietert PJ, Silverstein MD, Abboud MR. Sickle cell anemia: epidemiology and cost of illness. Pharmacoeconomics 2002;20:357-66.
4. De D. Sickle cell anaemia 1: background, causes and incidence in the UK. Br J Nurs 2005;14:447-50.
5. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-9.
6. Le Gallais D, Bile A, Mercier J, Paschel M, Tonellot JL, Dauverchain J. Exercise-induced death in sickle cell trait: role of aging, training, and deconditioning. Med Sci Sports Exerc 1996;28:541-4.
7. Slovis CM, Talley JD, Pitts RB. Non relationship of climatologic factors and painful sickle cell anemia crisis. J Chronic Dis 1986;39:121-6.
8. Krauss JS, Lawrence J, Freant LJ, Lee JR. Gastrointestinal pathology in sickle cell disease. Ann Clin Lab Sci 1998;28:19-23.
9. Johnson C. Gallbladder and liver disorders in sickle cell disease: a critical review. 2001. Available at http:/sickle.bwh.Harvard.edu/liver.html
10. Diggs LW. Sickle cell crisis. Am J Clin Pathol 1965;26:1109-18.
11. Sheehy TW. Sickle cell hepatopathy. South Med J 1977;70:533-8.
12. Schubert TT. Hepatobiliary system in sickle cell disease. Gastroenterology 1986;90:2013-21.
13. Hernandez P, Dorticos E, Espinosa E, Gonzalez X, Svarch E. Clinical features of hepatic sequestration in sickle cell anemia. Haematologia (Budap) 1989;22:169-74.
14. Banarjee S, Owe C, Chorpa S. Sickle cell hepatopathy. Hepatology 2001;3:1021-6.
15. Hatton CS, Bunch C, Weatherall DJ. Hepatic sequestration in sickle cell anaemia. Br Med J 1985;290:744-5.
16. The management of sickle cell disease. (Revised June 2002). NHI Publication 02-117. Available at http:/www.nhlbi.nih.gov/health/prof/blood/ sickle/sc
17. Roth EF Jr, Bardfeld PA, Goldsmith SJ, Radel E, Williams JC. Sickle cell crisis as evaluated from measurements of hydroxybutyrate dehydrogenase and myoglobin in plasma. Clin Chem 1981;27:314-6.
18. Corazza GR, Ginaldi L, Zoli G, Frisoni M, Lalli G, Gasbarrini G, et al. Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol 1990;2:269-75.
19. Gorg C, Elickorn M, Zugaier G. The small spleen: sonographic patterns of functional hyposplenia or asplenia. J Clin Ultrasound 2003;31:152-5.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
21. Hiran S. Multiorgan dysfunction syndrome in sickle cell disease. J Assoc Physicians India 2005;53:19-22.
22. Williams EN. Acute hepatic sequestration in sickle cell disease. J Natl Med Assoc 2004;96:1235-9.
23. Shao SH, Orninger EP. Sickle cell intrahepatic cholestasis: approach to a difficult problem. Am J Gastroenterol 1995;90:2048-50.
24. Hatton CS, Bunch C, Weatherall DJ. Hepatic sequestration in sickle cell anaemia. Br Med J (Clin Res ed) 1985;290:744-5.
25. Johnson CS, Omata M, Tong MJ, Simmons JF, Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine 1985;64:349-56.
26. Isichei UP. Liver function and diagnostic significance of biochemical changes in the blood of African children with sickle cell disease. J Clinic Path 1980;33:626-30.
27. Osifo BOA, Adeyokunnu A. serum aminotransferase activities in sickle cell children during crisis. Acta Tropica 1984;41:173-9.
28. Qjuawo A, Adedoyin MA, Fagbbule D. Hepatic function tests in children with sickle cell anaemia during vaso-occlusive crisis. Central Afr J Med 1994;40:342-5.
29. Rosenblate HJ, Eisentein R, Holmes AW. The liver in sickle cell anemia. A clinical-pathology study. Arch Pathol 1970;90:235-45.
30. Song YS. Hepatic lesions in sickle cell anemia. Am J Path 1957;33:331-51.
31. Bauer TN, Moore G, Hutchins GM. The liver in sickle cell disease. Am J Med 1980;69:833-7.
32. Charlote F, Bachir D, Nenert M, Mavier P, Galacteros F, Dhumeaux D, et al. Vascular lesions of the liver in sickle cell disease. A clinicopathological study of 26 living patients. Arch Pathol Lab Med 1995;119:46-52.
33. Teixeira AL, Viana MB, Roquette ML, Toppa NH. Sickle cell disease: a clinical and histopathologic study of the liver in living children. J Pediatr Hematol Oncol 2002;24:125-9.
34. Omata M, Johnson CS, Tong MJ, Simmons JF, Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine 1985;111:571-6.
35. Blum A, Yeganeh S, Peleg A, Vigder F, Kryuger K, Khatib A, et al. Endothelial function in patients with sickle cell anemia during and after sickle cell crises. J Thromb Thrombolysis 2005;19:83-6.
36. Assis A, Conran N, Canalli AA, Lorand-Metze I, Saad ST, Costa FF. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin. Acta Haematol 2005;113:130-6.
37. Somjee SS, Warrier RP, Thomson JL, Ory-Ascani J, Hempe JM. Advanced glycation end-products in sickle cell anaemia. Br J Haematol 2005;128:112-8.
38. Adewoye AH, Klings ES, Farber HW, Palaima E, Bausero MA, McMahon L, et al. Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70. Am J Hematol 2005;78:240-2.
39. Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D. Cytokine profile of sickle cell disease in Oman. Am J Hematol 2004;77:323-8.
40. Mallouh AA, Asha MI. Acute cholestatic jaundice in children with sickle cell disease: hepatic crises or hepatitis? Ped Inf Dis J 1988;7:689-92.
41. Stephan JL, Merpit-Gonon E, Richard O, Raynaud-Ravni C, Freycon F. Fulminant liver failure in a 12-year-old girl with sickle cell anemia: favorable outcome after exchange transfusions. Eur J Peds 1995;154:469-71.
42. Samperi P, Consalvo C, Romano V, Geladrdi S, Di Bella D, Schiliro G. Liver involvement in white patients with sickle-cell disease. Arch Peds Adolesc Med 1996;150:1177-80.
43. Betrosian A, Balla M, Kafiri G, Palamarou C, Sevastos N. Reversal of liver failure in sickle-cell vaso-occlusive crisis. Am J Med Sci 1996;311:292-5.
44. Jeng MR, Riemann MD, Naidu PE. Resolution of chronic hepatitis sequestration in a patient with homozygous sickle cell disease. J Ped Hematol Oncol 2003;25:257-60.
45. Mouele R, Boukila V, Fourcade V, Feingold J, Galacteros F. Sickle-cell disease in Brazzaville, Congo: genetical, hematological, biochemical and clinical aspects. Acta Hematol 1999;101:178-84.
46. Chopra R, Al-Mulhim AR, Al-Baharani AT. Fibrocongestive splenomegaly in sickle cell disease: a distinct clinicopathological entity in the Eastern province of Saudi Arabia. Am J Hematol 2005;79:180-6.